In This Section

Advocacy Detail

- Latest ASPET News
- Statement
- Advocacy News
May 10, 2022

ASPET and the Friends of the VA Endorse a Recommendation of $980 Million for the VA’s Medical and Prosthetic Research Program for FY 2023

ASPET and FOVA Recommendations for FY 2023, Department of Veterans Affairs
- Statement
April 11, 2022

ASPET Provides Comments to the NIH on Its DEIA Strategic Plan Framework

The purpose of the plan is to articulate NIH’s vision for embracing, integrating, and strengthening DEIA at NIH.
- News
- Latest ASPET News
- Advocacy News
March 30, 2022

ASPET Prescribed Policy, March 2022

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Statement
March 30, 2022

ASPET Joins with NABR and the Scientific Community to Defend Animal Research at NIH

The letter follows demands from several members of Congress that NIH stop funding studies using animal models.
- News
- Latest ASPET News
- Advocacy News
February 28, 2022

ASPET Prescribed Policy, February 2022

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Statement
February 04, 2022

ASPET Joins over 50 Scientific Societies in Urging Congress to Finalize FY22 Appropriations with Robust Support for Scientific R&D

The current continuing resolution funding the government at FY21 levels expires on February 18.
- News
- Latest ASPET News
- Advocacy News
January 28, 2022

ASPET Prescribed Policy, January 2022

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- News
- Latest ASPET News
- Advocacy News
December 30, 2021

ASPET Prescribed Policy, December 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Statement
December 16, 2021

ASPET Submits Letter to the House Energy and Commerce Committee on the Interagency Proposal to Class Schedule Fentanyl-related Substances

The proposal contains provisions that will streamline the process for conducting research with Schedule I drugs
- News
- Latest ASPET News
- Advocacy News
November 23, 2021

ASPET Prescribed Policy, November 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Statement
November 11, 2021

ASPET and the Friends of the VA Urge Congress to Adopt the House’s Funding Level for FY 22 Appropriations

The $904m appropriation will ensure continuation of the best medical research for our veterans.
- Statement
November 10, 2021

ASPET Endorses the Coalition for NSF’s Response to FY 23 R&D Policy Recommendations from OSTP and OMB

The recommendations include a focus on pandemic readiness and prevention and STEM education.
- Statement
November 10, 2021

ASPET joins with the Coalition for NSF Funding to urge appropriators to provide $9.634b to NSF for FY 22

The figure represents the higher of the two appropriations numbers for the agency put forward by the House and Senate.
- News
- Latest ASPET News
- Advocacy News
October 28, 2021

ASPET Prescribed Policy, October 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Statement
October 27, 2021

ASPET and Research! America encourage Congress to finish the FY 22 appropriations process

Continuing resolutions stall progress and impede our ability to make scientific and technological advances
- Advocacy News
August 27, 2021

ASPET Prescribed Policy, September 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Advocacy News
August 27, 2021

ASPET Prescribed Policy, August 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Advocacy News
July 30, 2021

ASPET Prescribed Policy, July 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.
- Statement
July 19, 2021

ASPET provides feedback on “Cures 2.0” discussion draft to the House Committee on Energy and Commerce

The draft includes an authorization for the creation of ARPA-H and research relief funding via the RISE Act.
- Advocacy News
July 02, 2021

ASPET Prescribed Policy, June 2021

The latest issue of ASPET's Prescribed Policy newsletter is available now.

1 2 3 4 5 6 7 8 9 10 ...